Plain-English translation of NCT07114120 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This clinical trial is testing whether Bailing Capsules combined with Guben Kechuan Granules—two herbal medicines—can help treat stable bronchiectasis when added to standard medical care. Bronchiectasis is a lung condition where the airways become damaged and inflamed, causing repeated infections and flare-ups. Researchers want to see if this combination treatment reduces how often these flare-ups happen and is safe to use.
People with stable bronchiectasis often experience frequent, serious flare-ups that disrupt their lives. Doctors are looking for additional treatment options that, when combined with standard care, might reduce these flare-ups and help patients breathe better.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to either take the herbal medicines plus standard treatment or standard treatment alone for 24 weeks. You'll take capsules and granules by mouth three times daily, keep a symptom diary, and visit the clinic for checkups and tests at 4, 12, 24, and 48 weeks. The study team will monitor you closely to see how the treatment affects your flare-ups and overall lung health.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
China